1350759-56-6

Basic information

• Product Name: 4-{8-[3-cyclopropyl-4-(trifluoromethyl)benzyl]-1-oxa-2,8-diazaspiro[4.5]dec-2-en-3-yl}benzoic acid trifluoroacetate
• Synonyms: 4-{8-[3-cyclopropyl-4-(trifluoromethyl)benzyl]-1-oxa-2,8-diazaspiro[4.5]dec-2-en-3-yl}benzoic acid trifluoroacetate
• CAS NO: 1350759-56-6
• Molecular Weight: 572.504
• Mol File: 1350759-56-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-{8-[3-cyclopropyl-4-(trifluoromethyl)benzyl]-1-oxa-2,8-diazaspiro[4.5]dec-2-en-3-yl}benzoic acid trifluoroacetate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-{8-[3-cyclopropyl-4-(trifluoromethyl)benzyl]-1-oxa-2,8-diazaspiro[4.5]dec-2-en-3-yl}benzoic acid trifluoroacetate(1350759-56-6)
• EPA Substance Registry System: 4-{8-[3-cyclopropyl-4-(trifluoromethyl)benzyl]-1-oxa-2,8-diazaspiro[4.5]dec-2-en-3-yl}benzoic acid trifluoroacetate(1350759-56-6)

Safety Data

• Hazardous Substances Data: 1350759-56-6(Hazardous Substances Data)

Upstream product

• 126689-01-8 cyclopropylboronic acid pinacol ester 
• 1350761-98-6 methyl 4-{8-[3-bromo-4-(trifluoromethyl)benzyl]-1-oxa-2,8-diazaspiro[4.5]dec-2-en-3-yl}benzoate 
• 76-05-1 trifluoroacetic acid 

Relevant articles and documents

SPIRO ISOXAZOLINE COMPOUNDS AS SSTR5 ANTAGONISTS

Substituted spirocyclic amines of structural formula (I) are selective antagonists of the somatostatin subtype receptor 5 (SSTR5) and are useful for the treatment, control or prevention of disorders responsive to antagonism of SSTR5, such as Type 2 diabetes, insulin resistance, lipid disorders, obesity, atherosclerosis, Metabolic Syndrome, depression, and anxiety.